Compare
5 stocks, side by sideRelative performance · rebased to 100
REGNARGXALNYRVMDVRTX
| REGNRegeneron Pharmaceuticals | ARGXargenx SE | ALNYAlnylam Pharmaceuticals, Inc. | RVMDRevolution Medicines, Inc. | VRTXVertex Pharmaceuticals | |
|---|---|---|---|---|---|
| Smart Score | 9/10 | 7/10 | 8/10 | 10/10 | 8/10 |
| Price | $623.43 | $888.65 | $293.17 | $178.17 | $475.20 |
| 1 month | -2.4% | +9.9% | -0.79% | +15% | +9.4% |
| 1 year | +22% | +56% | -9.8% | +345% | +7.1% |
| 5 year | +20% | +182% | +70% | +423% | +153% |
| P/E (TTM) | 14.7 | 37.1 | 67.8 | -27.6 | 28.0 |
| P/E vs sector | - | +18% | +115% | - | - |
| Market cap | $63.9B | $55.5B | $39.1B | $37.9B | $114.6B |
| Sector | Health Care | Healthcare | Healthcare | Healthcare | Health Care |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.